Parkwalk Growth Technology Funds invest in innovative British high-growth companies to seek capital appreciation with the added advantages to investors of the tax reliefs offered under the Enterprise Investment Scheme (EIS) and Business Investment Relief (BIR).More
In conjunction with Cambridge Enterprise, the University’s TTO, Parkwalk manage the University of Cambridge Enterprise Funds, allowing alumni and supporters of the University unique access to deal-flow. Fund III is expected to open to new investors in H2 2014. More
In conjunction with Isis Innovation, the University’s TTO, Parkwalk manage the University of Oxford Isis Funds, allowing alumni and supporters of the University of Oxford unique access to deal-flow. The first Fund closed to new investors in Q1 2014, Fund II is expected in Q4 2014.More
Parkwalk raises equity and debt capital for corporate clients through public and private markets. The Firm offers non-conflicted strategic advisory services to high-growth SMEs, often working with in-situ advisers and brokers to achieve the best results.More

Parkwalk growth technology EIS Funds

Parkwalk Funds seek capital appreciation with the added advantages to investors of the tax reliefs offered under the Enterprise Investment Scheme (EIS) and Business Investment Relief (BIR).

Each Parkwalk Fund invests in a minimum of five companies, and investee companies range from early stage through to AIM-listed, creating a diverse portfolio of sectors and business development stages, with capital raised used for development, commercialisation and expansion through to acquisition capital.

Parkwalk manages a series of EIS Funds, including the University of Cambridge Enterprise Funds and the University of Oxford Isis Funds, allowing our investors access to some of the world’s highest calibre discoveries and IP.

All of Parkwalk’s fully-invested Funds are currently valued at a premium to original investment cost.

Parkwalk EIS Funds

Parkwalk UK Tech Fund V
The Parkwalk Technology Funds seek to generate multiple returns by investing across a portfolio of companies whose proprietary IP or know-how originated from UK R&D intensive institutions and Universities, whilst providing significant tax reliefs to the individual investor through the Enterprise Investment Scheme.
Parkwalk’s current portfolio consists of over 27 companies, which have raised in excess of £250m of funding between them since 2010 and over 600 patents protect their technology and processes.

  • sector diversification of investee companies
  • investments range from early stage through to AIM-listed
  • positive reviews by Allenbridge TSR and Churchill TER
  • click here to email the funds team to request further information
University of Cambridge Enterprise Fund III
University of Oxford Isis Fund II
Exits

Parkwalk Recent Investments

Parkwalk Funds seek capital appreciation to generate multiple returns by investing across a portfolio of companies whose proprietary IP or know-how originated from UK Universities, whilst providing significant tax reliefs to the individual investor through the Enterprise Investment Scheme.